CoChat

Comparison of a brush‐sampling fecal immunochemical test for hemoglobin with a sensitive guaiac‐based fecal occult blood test in detection of colorectal neoplasia

Fletcher, Robert H., Ransohoff, David F., Imperiale, Thomas F. · 2007 · Cancer
Cited by 151

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Smith et al.1 compared the performance of a fecal immunochemical test (FIT) for hemoglobin to a sensitive, guaiac-based fecal occult blood test (GFOBT) in a large cohort of average-risk adults and found that the FIT was more sensitive for cancers and significant adenomas. They report that “…the FIT returned a true-positive result…in cancer…[of] 87.5%.” Readers should not mistake this result for the true sensitivity in the usual sense: the proportion of all patients with cancer who have a positive test. The study by Smith et al was conducted in such a way that true sensitivity is necessarily overestimated and easily can approach 100%. Almost all participants in this study underwent colonoscopy only if 1 of the 2 fecal occult blood tests was positive. Patients with cancer who had negative tests—which would have been counted as false-negative results, causing lower sensitivity—systematically were excluded. This problem, known as diagnostic work-up bias,2 would have been avoided only by performing colonoscopy on all members of the cohort, regardless of the test results.3 The extent to which the reported “true-positive rate” may have overestimated true sensitivity is illustrated by the following example: The literature suggests that no more than half of colorectal cancers bleed at a given point in time. If so, then at least 48 of the 2512 study participants would have had cancer, not just the 24 that were diagnosed because they bled, causing 1 or both of the tests to be positive. The true sensitivity for FIT then would have been 21 of 48 (43.8%), and not the 21 of 24 (87.5%) reported. Taking into account statistical uncertainty (the 95% confidence interval), sensitivity would have been in the 29% to 58% range. The “true positive rate” used for comparing 2 tests within a study like the one by Smith et al1 is not a valid estimate of true sensitivity for comparison with the sensitivities of other tests reported in the literature. Robert H. Fletcher MD, MSc*, David F. Ransohoff MD , Thomas F. Imperiale MD , * Department of Ambulatory Care and Prevention, Harvard Medical School Cambridge, Massachusetts, Division of Gastroenterology, Department of Medicine, University of North Carolina Chapel Hill, North Carolina, Division of Gastroenterology, Department of Medicine, Indiana University School of Medicine Indianapolis, Indiana.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.22611

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Fletcher, R. H., Ransohoff, D. F., & Imperiale, T. F.
Venue
Cancer
Publisher
Wiley
Published
2007-04-18
Volume
109
Issue
9
Pages
1925-1926
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2140491861
Cited by
151
References
1
FWCI
8.00
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.